{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:46:21Z","timestamp":1790545581995,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/npp.2015.188","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T11:02:37Z","timestamp":1435143757000},"page":"686-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior"],"prefix":"10.1038","volume":"41","author":[{"given":"Samantha E","family":"Yohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector M","family":"Contreras-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L","family":"Errante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merce","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"BFnpp2015188_CR1","first-page":"504","volume":"166","author":"PH Anderson","year":"1989","unstructured":"Anderson PH (1989). The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166: 504.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2015188_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-2999(88)90068-4","volume":"158","author":"A Armario","year":"1988","unstructured":"Armario A, Gavald\u00e0 A, Mart\u00ed O (1988). Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate. Eur J Pharmacol 158: 207\u2013212.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2015188_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/1745017901309010142","volume":"9","author":"DS Bell","year":"2013","unstructured":"Bell DS, Shipman WM, Cleves MA, Siegelman J (2013). Which drug for which patient? Is there a fluoxetine responding versus a bupropion responding personality profile? Clin Pract Epidemiol Ment Health 9: 142\u2013147.","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"BFnpp2015188_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00213-010-2097-z","volume":"213","author":"GV Carr","year":"2011","unstructured":"Carr GV, Lucki I (2011). The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology 213: 265\u2013287.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015188_CR5","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.clinthera.2012.06.010","volume":"34","author":"JJ Chen","year":"2012","unstructured":"Chen JJ, Ondo WG, Dashtipour K, Swope DM (2012). Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther 34: 1487\u20131504.","journal-title":"Clin Ther"},{"key":"BFnpp2015188_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0269881113514878","volume":"28","author":"JA Cooper","year":"2014","unstructured":"Cooper JA, Tucker VL, Papakostas GI (2014). Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union. J Psychopharmacol 28: 118\u2013124.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2015188_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1741-7015-11-126","volume":"11","author":"BN Cuthbert","year":"2013","unstructured":"Cuthbert BN, Insel TR (2013). Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11: 126.","journal-title":"BMC Med"},{"key":"BFnpp2015188_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1461145704004729","volume":"8","author":"K Demyttenaere","year":"2005","unstructured":"Demyttenaere K, De Fruyt J, Stahl SM (2005). The many faces of fatigue in major depressive disorder. J Neuropsychopharmacol 8: 93\u2013105.","journal-title":"J Neuropsychopharmacol"},{"key":"BFnpp2015188_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbr.2012.10.051","volume":"243","author":"S Esumi","year":"2013","unstructured":"Esumi S, Sagara H, Nakamoto A, Kawasaki Y, Gomita Y, Sendo T (2013). Effect of GBR12909 on affective behavior: distinguishing motivational behavior from antidepressant-like and addiction-like behavior using the runway model of intracranial self-stimulation. Behav Brain Res 243: 313\u2013321.","journal-title":"Behav Brain Res"},{"key":"BFnpp2015188_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/da.22199","volume":"31","author":"M Fava","year":"2014","unstructured":"Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P et al (2014). Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depress Anxiety 31: 250\u2013257.","journal-title":"Depress Anxiety"},{"key":"BFnpp2015188_CR11","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/sj.npp.1301565","volume":"33","author":"SB Floresco","year":"2008","unstructured":"Floresco SB, Tse MT, Ghods-Sharifi S (2008). Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33: 1966\u20131979.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015188_CR12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2147\/NDT.S6430","volume":"6","author":"S Frank","year":"2010","unstructured":"Frank S (2010). Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease. Neuropsychiatr Dis Treat 6: 657\u2013665.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFnpp2015188_CR13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0006-3223(98)00235-2","volume":"44","author":"CM Gullion","year":"1998","unstructured":"Gullion CM, Rush AJ (1998). Toward a generalizable model of symptoms in major depressive disorder. Biol Psychiatry 44: 959\u2013972.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2015188_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/npp.2014.285","volume":"40","author":"JG Hosking","year":"2015","unstructured":"Hosking JG, Floresco SB, Winstanley CA (2015). Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost\/benefit decision-making tasks. Neuropsychopharmacology 40: 1005\u20131015.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015188_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1139\/y2012-045","volume":"90","author":"AL Hudson","year":"2012","unstructured":"Hudson AL, Lalies MD, Silverstone P (2012). Venlafaxine enhances the effect of bupropion on extracellular dopamine in rat frontal cortex. Canadian J Physiol Pharmacol 90: 803\u2013809.","journal-title":"Canadian J Physiol Pharmacol"},{"key":"BFnpp2015188_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2008.12.024","volume":"451","author":"DP Jang","year":"2009","unstructured":"Jang DP, Lee SH, Park CW, Lee SY, Kim YB, Cho ZH (2009). Effects of fluoxetine on the rat brain in the forced swimming test: a [F-18]FDG micro-PET imaging study. Neurosci Lett 451: 60\u201364.","journal-title":"Neurosci Lett"},{"key":"BFnpp2015188_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/sj.npp.1300341","volume":"29","author":"MM Katz","year":"2004","unstructured":"Katz MM, Tekell JL, Bowden CL, Brannan S, Houston JP, Berman N et al (2004). Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 29: 566\u2013579.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015188_CR18","volume-title":"Design and Analysis: A Researcher's Handbook","author":"G Keppel","year":"1991","unstructured":"Keppel G (1991) Design and Analysis: A Researcher's Handbook. Prentice-Hall: Upper Saddle River, NJ."},{"key":"BFnpp2015188_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3758\/s13415-011-0068-4","volume":"12","author":"B Mai","year":"2012","unstructured":"Mai B, Sommer S, Hauber W (2012). Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. Cogn Affect Behav Neurosci 12: 74\u201384.","journal-title":"Cogn Affect Behav Neurosci"},{"key":"BFnpp2015188_CR20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2013.04.010","volume":"78","author":"VB McGinty","year":"2013","unstructured":"McGinty VB, Lardeux S, Taha SA, Kim JJ, Nicola SM (2013). Invigoration of reward seeking by cue and proximity encoding in the nucleus accumbens. Neuron 78: 910\u2013922.","journal-title":"Neuron"},{"key":"BFnpp2015188_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00213-008-1441-z","volume":"204","author":"AM Mott","year":"2009","unstructured":"Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J et al (2009). The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost-benefit procedure. Psychopharmacology 204: 103\u2013112.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015188_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1017\/S0033291709006011","volume":"40","author":"AA Nierenberg","year":"2010","unstructured":"Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR et al (2010). Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med 40: 41\u201350.","journal-title":"Psychol Med"},{"key":"BFnpp2015188_CR23","doi-asserted-by":"publisher","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","volume":"33","author":"EJ Nunes","year":"2013","unstructured":"Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y et al (2013). Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci 33: 19120\u201319130.","journal-title":"J Neurosci"},{"key":"BFnpp2015188_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00213-013-3285-4","volume":"231","author":"EJ Nunes","year":"2014","unstructured":"Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA et al (2014). Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5\/chow feeding choice task. Psychopharmacology 231: 727\u2013736.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015188_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/0269881106069938","volume":"21","author":"D Nutt","year":"2007","unstructured":"Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL et al (2007). The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol 21: 461\u2013471.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2015188_CR26","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1345\/aph.1Q656","volume":"46","author":"PR Padala","year":"2012","unstructured":"Padala PR, Padala KP, Monga V, Ramirez DA, Sullivan DH (2012). Reversal of SSRI-associated apathy syndrome by discontinuation of therapy. Ann Pharmacother 46: e8.","journal-title":"Ann Pharmacother"},{"key":"BFnpp2015188_CR27","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.biopsych.2006.06.015","volume":"15","author":"GI Papakostas","year":"2006","unstructured":"Papakostas GI, Nutt DJ, Hallet LA, Tucker VL, Krishen A, Fava M (2006). Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 15: 1350\u20131355.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2015188_CR28","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s00213-015-3872-7","volume":"232","author":"M Pardo","year":"2015","unstructured":"Pardo M, L\u00f3pez-Crus L, Miguel NS, Salamone JD, Correa M (2015). Selection of sucrose concentration depends on the effort required to obtain it: studies using tetrabenazine, D1, D2, D3 receptor antagonists. Psychopharmacology 232: 2377\u20132391.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015188_CR29","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1038\/npp.2015.69","volume":"40","author":"SJ Podurgiel","year":"2015","unstructured":"Podurgiel SJ, Milligan MN, Yohn SE, Purcell LJ, Contreras-Mora HM, Correa M et al (2015). Fluoxetine administration exacerbates oral tremor and striatal dopamine depletion in a rodent pharmacological model of parkinsonism. Neuropsychopharmacology 40: 2240\u20132247.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015188_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-clinpsy-050212-185606","volume":"10","author":"DA Pizzagalli","year":"2014","unstructured":"Pizzagalli DA (2014). Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol 10: 393\u2013423.","journal-title":"Annu Rev Clin Psychol"},{"key":"BFnpp2015188_CR31","doi-asserted-by":"publisher","first-page":"e47934","DOI":"10.1371\/journal.pone.0047934","volume":"7","author":"PA Randall","year":"2012","unstructured":"Randall PA, Pardo M, Nunes EJ, L\u00f3pez Cruz L, Vemuri VK, Makriyannis A et al (2012). Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS One 7: e47934.","journal-title":"PLoS One"},{"key":"BFnpp2015188_CR32","doi-asserted-by":"publisher","first-page":"e99320","DOI":"10.1371\/journal.pone.0099320","volume":"9","author":"PA Randall","year":"2014","unstructured":"Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B et al (2014). The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio\/chow feeding choice task: reversal with antidepressant drugs. PLoS One 9: e99320.","journal-title":"PLoS One"},{"key":"BFnpp2015188_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu017","volume":"18","author":"PA Randall","year":"2015","unstructured":"Randall PA, Lee CA, Podurgiel SJ, Hart E, Yohn SE, Jones M et al (2015). Bupropion increases selection of high effort activity in rats tested on a progressive ratio\/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol 18: 1\u201311.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFnpp2015188_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00213-006-0528-7","volume":"191","author":"TW Robbins","year":"2007","unstructured":"Robbins TW, Everitt BJ (2007). The role for mesencephalic dopamine in activation: commentary on Berridge. Psychopharmacology (Berl) 191: 433\u2013437.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2015188_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2013.08.008","volume":"55","author":"AJ Rothschild","year":"2014","unstructured":"Rothschild AJ, Raskin J, Wang CN, Marangell LB, Fava M (2014). The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder. Compr Psychiatry 55: 1\u201310.","journal-title":"Compr Psychiatry"},{"key":"BFnpp2015188_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0166-4328(02)00282-6","volume":"137","author":"JD Salamone","year":"2002","unstructured":"Salamone JD, Correa M (2002). Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137: 3\u201325.","journal-title":"Behav Brain Res"},{"key":"BFnpp2015188_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone JD, Correa M (2012). The mysterious motivational functions of mesolimbic dopamine. Neuron 76: 470\u2013485.","journal-title":"Neuron"},{"key":"BFnpp2015188_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035063","volume":"305","author":"JD Salamone","year":"2003","unstructured":"Salamone JD, Correa M, Mingote S, Weber SM (2003). Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther 305: 1\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2015188_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","volume":"191","author":"JD Salamone","year":"2007","unstructured":"Salamone JD, Correa M, Farrar A, Mingote SM (2007). Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191: 461\u2013482.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015188_CR40","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1038\/sj.npp.1301368","volume":"32","author":"AC Sanders","year":"2007","unstructured":"Sanders AC, Hussain AJ, Hen R, Zhuang X (2007). Chronic blockade or constitutive deletion of the serotonin transporter reduces operant responding for food reward. Neuropsychopharmacology 32: 2321\u20132329.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015188_CR41","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1037\/0735-7044.119.6.1687","volume":"119","author":"J Schweimer","year":"2005","unstructured":"Schweimer J, Saft S, Hauber W (2005). Involvement of catecholamine neurotransmission in the rat anterior cingulate in effort-related decision making. Behav Neurosci 119: 1687\u20131692.","journal-title":"Behav Neurosci"},{"key":"BFnpp2015188_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1101\/lm.409306","volume":"13","author":"J Schweimer","year":"2006","unstructured":"Schweimer J, Hauber W (2006). Dopamine D1 receptors in the anterior cingulate cortex regulate effort-related decision making. Learn Mem 13: 777\u2013782.","journal-title":"Learn Mem"},{"key":"BFnpp2015188_CR43","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/npp.2012.69","volume":"37","author":"N Shafiei","year":"2012","unstructured":"Shafiei N, Gray M, Viau V, Floresco SB (2012). Acute stress induces selective alterations in cost\/benefit decision-making. Neuropsychopharmacology 37: 2194\u20132209.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2015188_CR44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","volume":"196","author":"KS Sink","year":"2008","unstructured":"Sink KS, Vemuri VK, Olszewska T, Makriyannis A, Salamone JD (2008). Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology 196: 565\u2013574.","journal-title":"Psychopharmacology"},{"key":"BFnpp2015188_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4088\/JCP.v63n0102","volume":"63","author":"SM Stahl","year":"2002","unstructured":"Stahl SM (2002). The psychopharmacology of energy and fatigue. J Clin Psychiatry 63: 7\u20138.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2015188_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.31887\/DCNS.1999.1.3\/gstotz","volume":"1","author":"G Stotz","year":"1998","unstructured":"Stotz G, Woggon B, Angst J (1998). Psychostimulants in the therapy of treatment-resistant depression. Dialogues Clin Neurosci 1: 165\u2013174.","journal-title":"Dialogues Clin Neurosci"},{"key":"BFnpp2015188_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mehy.2012.10.007","volume":"80","author":"E Stenman","year":"2013","unstructured":"Stenman E, Lilja A (2013). Increased monoaminergic neurotransmission improves compliance with physical activity recommendations in depressed patients with fatigue. Med Hypotheses 80: 47\u201349.","journal-title":"Med Hypotheses"},{"key":"BFnpp2015188_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1142\/S0192415X0000012X","volume":"28","author":"T Tadano","year":"2000","unstructured":"Tadano T, Nakagawasai O, Jiijima F, Tan-No K, Kisara K (2000). The effects of traditional tonics on fatigue in mice differ from those of the antidepressant imipramine: a pharmacological and behavioral study. Am J Chin Med 28: 97\u2013104.","journal-title":"Am J Chin Med"},{"key":"BFnpp2015188_CR49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","volume":"35","author":"MT Treadway","year":"2011","unstructured":"Treadway MT, Zald DH (2011). Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35: 537\u2013555.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2015188_CR50","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1037\/a0028813","volume":"121","author":"MT Treadway","year":"2012","unstructured":"Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012). Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121: 553\u2013558.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp2015188_CR51","first-page":"153","volume":"14","author":"A Tylee","year":"1999","unstructured":"Tylee A, Gastpar M, L\u00e9pine JP, Mendlewicz J (1999). Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) survey. Int Clin Psychopharmacol 14: 153\u2013165.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFnpp2015188_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-5-18","volume":"5","author":"H Wang","year":"2010","unstructured":"Wang H, Chen X, Li Y, Tang TS, Bezprozvanny I (2010). Tetrabenazine is neuroprotective in Huntington\u2019s disease mice. Mol Neurodegener 5: 18.","journal-title":"Mol Neurodegener"},{"key":"BFnpp2015188_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejphar.2004.09.057","volume":"504","author":"J Yamada","year":"2004","unstructured":"Yamada J, Sugimoto Y, Yamada S (2004). Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol 504: 207\u2013211.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2015188_CR54","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","volume":"232","author":"SE Yohn","year":"2015","unstructured":"Yohn SE, Thompson C, Randall PA, Lee CA, M\u00fcller CE, Bagi Y et al (2015). The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology 232: 1313\u20131323.","journal-title":"Psychopharmacology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2015188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015188","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2015188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:52:23Z","timestamp":1684453943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2015188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFnpp2015188"],"URL":"https:\/\/doi.org\/10.1038\/npp.2015.188","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,24]]},"assertion":[{"value":"26 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}